Bupropion as a modulator of drug activity | Patent Publication Number 20220313689

US 20220313689 A1

Patent NumberUS 11969421 B2

Application Number17841274

Filled DateJun 15, 2022

Priority DateNov 5, 2013

Publication DateOct 6, 2022

Original AssigneeAxsome Therapeutics Inc.

Current AssigneeAntecip Bioventures Ii Llc Axsome

Inventor/ApplicantsHerriot Tabuteau

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.